CME Ventures

CME Ventures is the corporate venture capital arm of CME Group, the world's leading derivatives marketplace operating the CME, CBOT, NYMEX, and COMEX exchanges. Founded in 2014 and based in Chicago, Illinois, the fund drives strategic growth and shareholder value by investing in disruptive early-stage technology companies at the frontier of financial markets. The team brings more than 50 combined years of experience across capital markets, technology, and institutional finance. Since inception, CME Ventures has made 57 investments across seed through Series B stages, with checks typically ranging from $3 million to $20 million. The portfolio spans fintech and capital markets technology, AI, data analytics, and enterprise software, with geographic reach across the United States, Canada, Europe, and Asia. Notable portfolio companies include Synthesis Health, Kemiex, and SandboxAQ. By drawing on CME Group's position at the center of global financial market infrastructure, CME Ventures offers portfolio companies unparalleled access to institutional customers, market data, and regulatory relationships. CME Ventures operates as a strategic investor rather than a purely financial one — seeking both return and operational synergy between portfolio companies and CME Group's global exchange ecosystem. This gives the fund a distinctive value proposition: founders gain not just capital but a direct line into one of the most consequential institutions in global financial markets.